Flextothink Recognized as Most Promising Investment in Biomedical and Medical Device Category of 'New Quality Productive Forces' Initiative

On October 18, the much-anticipated "New Quality Productive Forces" investment and financing matchmaking event for the biopharmaceutical and medical device sector gained widespread attention in the industry. This event aims to consolidate resources from the government, industry, and financial sectors to promote the effective integration of the biopharmaceutical and medical device industries with technological innovation and financial resources, further enhancing the effectiveness of investment attraction and accelerating the cultivation and development of new quality productive forces. FlectoThink stood out in this event and was honored.“Enterprise with the Most Investment Potential”The award has injected strong momentum into the company's future development.

Chen Gang, Chief Medical Officer of FlectoThink

This event has a significant impact on the industry, bringing together many outstanding biopharmaceutical and medical device companies, as well as representatives from well-known investment institutions and financial organizations within and outside the province. FlectoThink, a leader in the field of non-invasive brain-computer interface technology, has won unanimous praise from experts and investors present for its excellent performance in technological innovation, product application, and market prospects.

During this event, FlectoThink showcased its latest R&D achievements in non-invasive brain-computer interface technology, including applications of flexible electrode EEG technology in sleep monitoring, mental health screening, and chronic disease rehabilitation management, as well as AI algorithm-based digital mental health programs. These innovative technologies and products not only have broad market prospects but also provide intelligent solutions for the healthcare industry, driving the digital transformation and high-quality development of the sector.

Looking ahead, FlectoThink will continue to uphold the mission of "integrating brain-computer interface technology into society to create a better life," focusing on building a brain-computer interface technology application system closely related to human life. The company will continue to increase investment in research and development, promote technological innovation and the transformation of results, provide more intelligent solutions for the healthcare field, and contribute greater strength to the sustainable development of society.

At the same time, FlectoThink will actively seek cooperation opportunities with partners from all sides to jointly promote the innovation and development of brain-computer interface technology. We believe that, with the joint efforts of all parties, FlectoThink will embrace an even more brilliant tomorrow!